Avacta Group plc appoints Zeus Capital as Joint Broker

02 Apr 2020

Avacta Group plc (AIM: AVCT), the developer of Affimer ®biotherapeutics and research reagents , is pleased to announce the appointment of Zeus Capital Limited as joint broker with immediate effect.